Glycosylated haemoglobin (HbAl), as an assessment of overall control, was estimated in 858 insulin-treated diabetics attending for changeover to U100 insulin in North East Wales. Details of age, sex, duration of diabetes, insulin regimen and monitoring method were recorded. Multivariate analysis revealed lower HbAl in patients receiving twice-daily (mean 11.01) as compared with once-daily insulin (1 1.42, P= 0.01 1), but no difference was found between urine and blood glucose testers when other variables were taken into consideration. HbA1 was lower in men (mean 10.94) compared with women (mean 11.39, P=0.004) and there was a positive correlation of HbA1 in men with age (P=0.046) and in women with duration of disease (P = 0.005).
Introduction
The changeover to U100 insulin presented us with an opportunity to identify people with insulin-treated diabetes in our district. We recorded their clinical details and collected a single blood sample from each patient for the estimation of glycosylated haemoglobin (HbA 1). This reflects the average or integrated blood glucose concentration over the previous two to three months (Koenig et al. 1976 , Gonen et al. 1977 and is an accurate and reproducible indicator of metabolic control in patients with diabetes mellitus (Dunn et al. 1979) .
Methods Patients
Eight hundred and fifty-eight persons with insulin-treated diabetes who attended U100 changeover clinics in North East Wales were studied. Details of age, sex and duration of diabetes were recorded together with their insulin regimen (onceor twice-daily insulin) and monitoring method.
Haemoglobin Al Venepuncture samples were collected into buffered edetic acid (EDTA). To minimize possible interference from 'labile fractions', samples were stored for not less than 24 hours at 4°C and thereafter were analysed employing reagents, microcolumns and calibrators in the analytical kit as supplied by Bio-Rad Laboratories, Caxton Way, Watford, Herts. Between-batch coefficients of variation did not exceed 6.0% measured at 3 levels spanning the physiological range. A reference range of 6.0% to 8.3% was established in 50 subjects who were nondiabetic.
Statistical analysis
The data were analysed using the Statistical Package for the Social Sciences (SPSS), version 8, on the 1904S/7600 computer at the University of Manchester Regional Computer Centre.
Populations were compared using analysis of variance with correction for co-variates. Correlation between variables was calculated using the method of partial correlation coefficients; use of this statistical method allows control of variables other than those under study. Full details of the computer program and statistical usage are given in the SPSS manual (Nie et al. 1975) . Univariate statistics were calculated using conventional methods.
Results
Haemoglobin Al was found to be normally distributed with a mean of 11.11% and standard deviation of 2.21% for the entire diabetic population studied. Using previously defined criteria (Gonen et al. 1979) , 29.6% were well controlled (HbAl < 10%) and 38.7% had acceptable but by no means very good control (HbA1 10-12%). Insulin regimen: Patients on twice-daily insulin (67%) had a significantly lower HbA1 -(mean 11.01, s.e. (mean) 0.089) compared with those on a once-daily regimen (mean 11.42, s.e. (mean) 0.14, P = 0.01 1) by analysis of variance which removed the effects of sex, age, duration and monitoring method (Table 1) .
Monitoring method: Fourteen percent of patients monitored with visually-read strips, 4% were meter users and 82% were urine testers. No significant difference in HbA1 was found between the groups when the effects of sex, age, duration and regimen were removed.
Sex: Men had significantly lower HbA1 (mean 10.94, s.e. (mean 0.093) compared with women (mean 11.39, s.e. (mean) 0.12, P=0.004) when the effects of age, duration of diabetes, dosage regimen and type of monitoring were removed (Table 1) . Age: A significant (P = 0.046) positive correlation was obtained between HbA1 and increasing age in men when the effects of duration, regimen and monitoring method were removed. No such correlation was found in women. Duration: A significant (P = 0.005) positive correlation was obtained between HbA1 and duration of diabetes in women when the effects of age, regimen and monitoring method were removed. No such correlation was found in men.
Discussion
Multivariate analysis allowed us to determine which factors independently affected HbA1 in this population of insulin-treated diabetics. Our results confirm that twice-daily insulin is the preferred regimen. This has long been considered the treatment of choice (Watkins 1982 ) and patients receiving twice-daily insulin have previously been shown to have lower mean blood glucose levels than those on a single daily insulin injection (Paisey et al. 1982) . Home glucose monitoring with meter-read test strips has been shown to lead to an improvement in control in the majority of patients (Sonksen et al. 1978 , Walford et al. 1978 ), but in this study we found no significant difference in HbA1 between urine testers and those who performed home blood glucose monitoring. Intensive education has been shown to improve control without any further advantage from home blood glucose monitoring (Worth et al. 1982 ) and a recent survey in one of our clinics (in preparation) has revealed that many of our patients perform insufficient tests and do not make independent adjustments to their insulin.
Women had significantly higher HbA1, suggesting poorer control than men. It is recognized that diabetic ketoacidosis is more common in women and that menstruation may have a profound effect on diabetic control (Walsh & Malins 1977) . The sex difference could, however, be due to different degrees of glycosylation for the same blood glucose levels (Stickland et al. 1984 ). An alternative explanation is that the higher HbA1 percentage in women is due to their lower total haemoglobin concentration, though in a smaller series non-diabetic men and women had virtually identical HbAl levels (Dunn et al. 1979) .
There was a positive correlation between HbA1 with age in men and with duration of diabetes in women. A positive correlation between HbAl and duration has previously been reported in a study of children and adolescents (Goldstein et al. 1980) . These results could be explained by reduced endogenous insulin secretion, increased insulin antibody formation or poor compliance. C-peptide levels as an indicator of insulin secretion have been shown to fall with duration of diabetes (Werther et al. 1982 ) and retention of endogenous insulin secretion has been associated with better glucose control (Block et al. 1973 ) and lower HbA1 (Paisey et al. 1982) . Levels of circulating insulin antibodies can also affect control as rechallenge of porcine-treated insulin patients with bovine insulin resulted in a rise in insulin antibodies, insulin dosage and HbA1 (Walford et al. 1982) .
The differences in HbA1 levels described above, although statistically significant, are small and may not be clinically important for the individual patient. They are, however, relevant to the practice of diabetic medicine and we conclude that twice-daily insulin is the preferred regimen, that control deteriorates with time and that home blood glucose monitoring alone does not lead to improved control.
